Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-17

FDA Approved: LACOSAMIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' lacosamide as an original application (ANDA) generic product. This marks the availability of a generic lacosamide for e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)